Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


Drug Discovery & Development (DDD2014)

17 Jun 2014 - 18 Jun 2014 - Online Event



Bookmark and Share


SELECTBIO is pleased to invite you to attend the first of our innovative online conferences; Drug Discovery & Development (DDD 2014). Using a pioneering new platform especially developed for scientific events, this event will be broadcast to your PC or mobile device on 17th-18th June 2014.

During this event, the hottest topics in Drug Discovery will be addressed in a webinar-style auditorium with the opportunity for live Q&A at the end of each talk. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in the design and development of drugs. Focus will be given to current developments in screening design, assay technology and compound management, as well as the emerging use of nanotechnology for drug delivery. Presentations will also highlight the increasing importance that academic centres play in drug discovery efforts, including drug repurposing and drug discovery for orphan diseases.
   
Benefits of attending this online event:

-    Opportunity to view posters, including an interactive session with the poster presenters.
-    Access to a virtual exhibit hall, enabling you to catch up with the latest technological developments in the industry via video, downloadable applications, brochures and interaction with booth staff.
-    View others in attendance and chat with them privately or in open forums.
-    No costs! No expensive flights, hotels or delegate fees.
-    Come & go as you please to fit around your busy life - you can attend at home or work using a PC or mobile device.

You can present your research on a poster while attending the meeting. Submit an abstract for consideration now!  Poster Submission Deadline: 06 June 2014





Further information
Scientific News
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!